User:Ana-Teresa Maia: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 4: Line 4:
*<b> Ana-Teresa Maia
*<b> Ana-Teresa Maia
Group Leader of Cancer Functional Genomics Group <br>
Group Leader of Cancer Functional Genomics Group <br>
Carrer Integration Grant Holder - Marie Curie <br>
Assistant Professor </b><br>
Assistant Professor </b><br>
IBB/CBME Laboratório Associado <br>
IBB/CBME Laboratório Associado <br>
Line 16: Line 17:
* 1999, MS, Imperial College of Science, Technology and Medicine, London, U.K.
* 1999, MS, Imperial College of Science, Technology and Medicine, London, U.K.
* 1997, BS, Faculty of Science and Technology, New University of Lisbon, Monte da Caparica, Portugal
* 1997, BS, Faculty of Science and Technology, New University of Lisbon, Monte da Caparica, Portugal
==Research Interests==
2012 - present : Assistant Professor, University of Algarve
Program in Regenerative Medicine, Department of Biomedical Sciences and Medicine
Maternity Leave: March 2013- September 2013
2012 - present : Group Leader, Associate Laboratory IBB/CBME
Cancer Functional Genomics Group
10/2008 – 12/2011 : Senior Research Associate, University of Cambridge    
Department of Oncology at Cambridge Research Institute-CRUK
Supervisor: Professor Sir Bruce Ponder
10/2006 - 9/2008 : Research Associate, University of Cambridge
Department of Oncology at Cambridge Research Institute-CRUK
Supervisor: Professor Sir Bruce Ponder
9/2003 - 9/2006 : Research Associate, University of Cambridge
Department of Oncology at Hutchison/MRC Institute
Supervisors: Professors Sir Bruce Ponder and Carlos Caldas
2/2001 : Visiting Student to Professor Andrea Biondi's group
Clinica Pediatrica dell’Università degli Studi di
Milano-Bicocca, Ospedale San Gerardo di Monza
9/1999 - 8/2003 : PhD Student, Institute of Cancer Research
Leukaemia Research Fund Centre
Supervisor: Professor Mel Greaves
9/1998 - 8/1999 : MSc Student, Imperial College of Science, Technology and Medicine
Supervisor: Professor Mel Greaves
9/1996 - 8/1998 : Researcher in training, New University of Lisbon          
Department of Genetics, Faculty of Medical Sciences


==Research Interests==
==Research Interests==
Line 36: Line 73:


</biblio>
</biblio>
==Lab Members==
*Joana Xavier, Post-doctoral Fellow
*Cátia Rocha, MSc Student
==Former Lab Members==
*Joana Lopes, MSc Student
*Inês Gomes, Undergraduate Student


==Funding==
==Funding==
Line 58: Line 86:
           * PBL classes to 1st and 2nd years
           * PBL classes to 1st and 2nd years
           * Seminars in Basic Sciences
           * Seminars in Basic Sciences
          * Coordinator of Student Chosen Module for 2 year (5 weeks training in laboratory or clinical work))


Masters of Science in Oncobiology - Molecular Mechanisms of Cancer
Masters of Science in Oncobiology - Molecular Mechanisms of Cancer

Latest revision as of 09:06, 27 October 2014

Contact Info

Ana-Teresa Maia (an artistic interpretation)
  • Ana-Teresa Maia

Group Leader of Cancer Functional Genomics Group
Carrer Integration Grant Holder - Marie Curie
Assistant Professor

IBB/CBME Laboratório Associado
Department of Biomedical Sciences and Medicine
University of Algarve
Gambelas, Faro, Portugal
Email me through OpenWetWare

Education

  • 2003, PhD, Institute of Cancer Research, London, U.K.
  • 1999, MS, Imperial College of Science, Technology and Medicine, London, U.K.
  • 1997, BS, Faculty of Science and Technology, New University of Lisbon, Monte da Caparica, Portugal

Research Interests

2012 - present : Assistant Professor, University of Algarve Program in Regenerative Medicine, Department of Biomedical Sciences and Medicine Maternity Leave: March 2013- September 2013

2012 - present : Group Leader, Associate Laboratory IBB/CBME Cancer Functional Genomics Group

10/2008 – 12/2011 : Senior Research Associate, University of Cambridge Department of Oncology at Cambridge Research Institute-CRUK Supervisor: Professor Sir Bruce Ponder

10/2006 - 9/2008 : Research Associate, University of Cambridge Department of Oncology at Cambridge Research Institute-CRUK Supervisor: Professor Sir Bruce Ponder

9/2003 - 9/2006 : Research Associate, University of Cambridge Department of Oncology at Hutchison/MRC Institute Supervisors: Professors Sir Bruce Ponder and Carlos Caldas

2/2001 : Visiting Student to Professor Andrea Biondi's group Clinica Pediatrica dell’Università degli Studi di Milano-Bicocca, Ospedale San Gerardo di Monza

9/1999 - 8/2003 : PhD Student, Institute of Cancer Research Leukaemia Research Fund Centre Supervisor: Professor Mel Greaves

9/1998 - 8/1999 : MSc Student, Imperial College of Science, Technology and Medicine Supervisor: Professor Mel Greaves

9/1996 - 8/1998 : Researcher in training, New University of Lisbon Department of Genetics, Faculty of Medical Sciences


Research Interests

I am interested in studying allelic imbalance in gene expression, a common feature of our genome. Due to regulatory polymorphisms, which can occur both in cis- and in trans-, a large number of our genes are preferentially expressed from one allele. This unequal expression can contribute to susceptibility to common diseases. My main aim is to try to use this concept to develop a new method to study predisposition to breast cancer. Additionally, I am investigating the role that this imbalance can play in tumour biology, namely in the effect of mutations and treatment response.

Publications

For all publications http://publicationslist.org/ana-teresa.maia

Selected Papers

  1. Curtis CN et al. (2012) Nature:486(7403):346-52 pmid= 22522925

    [Paper1]
  2. Maia AT et al. (2012) Breast Cancer Research:R63pmid= 22513257

    [Paper2]
  3. Maia AT et al. (2009) Breast Cancer Research:R88 pmid= 20003265

    [Paper3]
  4. Meyer KM, Maia AT et al. (2008) PLoS Biology:6(5):e108 pmid= 18462018

    [Paper4]
  5. Udler M, Maia AT et al. (2007) Journal of Clinical Oncology:25(21):3015-23 pmid= 17634480

    [Paper5]

Funding

  • 2013 - 2015 “Cis-regulation of somatic mutations in breast and ovarian cancers”; PTDC/BIM-ONC/1338/2012; Foundation for Science and Technology, Portugal
  • 2012 - 2016 Marie Curie Integration Grant, GenCar - Genetic Control of Gene Expression in Cancer Risk, FP7-MC-CIG, European Union
  • 2009 – 2010 Breast Cancer Research Foundation Grant, U.S.A., Differential Allelic Expression Analysis of Susceptibility Loci in Breast Cancer, USA
  • 2008 – 2009 Breast Cancer Research Foundation Grant, U.S.A., Differential Allelic Expression Analysis of Susceptibility Loci in Breast Cancer, USA

Teaching

Integrated Masters in Medicine

         * PBL classes to 1st and 2nd years
         * Seminars in Basic Sciences
         * Coordinator of Student Chosen Module for 2 year (5 weeks training in laboratory or clinical work))

Masters of Science in Oncobiology - Molecular Mechanisms of Cancer

         Vice-Director
         * Oncogenetics and Oncogenomics
         * Genetic Toxicology
         * Clinical Oncology

Masters of Science in BIomedical Sciences

         * Computational Biology

Undergraduate Degree in BIomedical Sciences

         * Human Genetics


Useful links